We are excited to announce a new collaborative partnership with Charles River Laboratories to accelerate academic drug discovery! This partnership integrates Autobahn’s expertise in venture creation and Charles River’s multidisciplinary drug discovery platforms to advance our growing pipeline of preclinical therapeutics programs. Charles River also joins our founding investor, Samsara BioCapital, in a fundraising round with proceeds that will be used to expand the number of partnerships with top-tier academic institutions, advance lead preclinical programs, and invest in new opportunities for therapeutics development. We look forward to working with Charles River and our academic partners to translate the best of academic biotech! Read more here. https://lnkd.in/enR9UAAj
Autobahn Labs, Inc.
Biotechnology
Palo Alto, CA 724 followers
Taking the brakes off innovative, early-stage academic science to accelerate development of novel therapeutics
About us
Autobahn Labs is a collaboration between a Samsara BioCapital-led investor syndicate and Charles River Laboratories. By combining Samsara's long-term investment philosophy with Charles River's world-class drug discovery and development capabilities we believe we can improve patient health by identifying exciting early-stage academic research projects that can spark the development of new therapeutics.
- Website
-
http://www.autobahn-labs.com
External link for Autobahn Labs, Inc.
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Palo Alto, CA
- Type
- Privately Held
Locations
-
Primary
Get directions
Palo Alto, CA 94301, US
Employees at Autobahn Labs, Inc.
Updates
-
Chief Scientific Officer at Autobahn Labs, a biotech accelerator funded by Samsara BioCapital and Charles River Laboratories
I will be at BIO in San Diego next week. Looking forward to sharing updates on our portfolio with potential partners. Learn more about Autobahn Labs at
Home - Autobahn Labs
autobahn-labs.com
-
Delighted to announce our first licenses from two of our outstanding partner institutions! It is further confirmation of Autobahn's model supporting early stage academic research!
Great to see the Autobahn Labs, Inc. #translationalresearch model, with its focus on the efficient #commercialization of promising #university #biomedical #technologies, continuing to see traction with its #Universitypartners and #academic #innovators. https://lnkd.in/gD9m_vyx
Autobahn Labs Announces Key Licensing Milestones in Alliances with Early University Partners
einpresswire.com
-
We're #hiring a new Analyst in Boston, Massachusetts. Apply today or share this post with your network.